Reforms may undermine NHS cost savings, say MPs
April 27, 2011NHS, NHS reform, Public Accounts Comittee
Radical reforms to the NHS in England could undermine the drive to save £20 billion over the next four years. …
Open Health recruits new associate partner
April 27, 2011Medical Communications appointment, medical communications
Margot Rozga has joined new med comms agency Open Health as an associate partner. The move to the Marlow, UK-based …
NICE gives final no to PharmaMar’s Yondelis
April 27, 2011Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer
A lack of evidence and an unconvincing patient access scheme has seen PharmaMar fail to win NICE backing for its …
CME Spotlight: education providers and pharma need guidance
April 27, 2011Medical Communications CME, CME Spotlight
Transplanting the testes and pituitary gland of a social outcast into a dog is the theme of a new opera …
Boehringer begins late-stage hep C trial
April 27, 2011Research and Development BI 201335, Boehringer Ingelheim, hepatitis C
Boehringer Ingelheim has begun enrolling patients in North America for a phase III trial of its chronic hepatitis C virus …
Digital Pharma: Bayer UK’s Twitter slip-up
April 26, 2011Medical Communications ABPI Code of Practice, Bayer, Digital Pharma blog, PMCPA, Twitter, medicial communications
There seems to be some confusion at Bayer UK over what communications can be sent over Twitter. The company is …
Bayer defends Yasmin against BMJ studies
April 26, 2011Sales and Marketing Bayer, Yasmin, contraception
Bayer has rallied strongly behind its top-selling contraceptive brand Yasmin after two studies in the British Medical Journal questioned the …
Merck & Co kicks off expansion of Durham vaccines facility
April 26, 2011Manufacturing and Production Merck & Co, manufacturing and production, vaccines
Merck & Co is expanding its vaccines facility in North Carolina, USA, bucking a recent trend at the manufacturer for …
Pharma manufacturing news in brief
April 26, 2011Manufacturing and Production Archer Daniels Midland, Dow Chemical, IPEC Americas, Pharmatek Laboratories, Taro, Taro Pharmaceutical Industries, Teva, Teva Pharmaceutical Industries, manufacturing, manufacturing news in brief, pharma manufacturing news
Includes a formulation problem for Teva, facility updates from Taro and ADM, and a new excipient screening initiative at the …
Deaths reported in Pfizer arthritis trial
April 26, 2011Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib
Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …
Anglo-Chinese joint venture makes first API batches
April 26, 2011Manufacturing and Production China, Hebei Aoxing Pharmaceutical, Macfarlan Smith, manufacturing and production
China’s Hebei Aoxing Pharmaceutical has passed a major milestone in its joint venture with process technology specialist Macfarlan Smith to …
Sten Westerberg joins BioInvent
April 26, 2011Research and Development appointment, research and development, sales and marketing
Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …
Top 5 reasons for a Class I product recall
April 21, 2011Manufacturing and Production Johnson & Johnson, product recalls
Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …
Digital Pharma: Boehringer UK tweets politicians with afib message
April 21, 2011Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications
Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …
WPP launches UK healthcare digital division
April 21, 2011Medical Communications Ogilvy, Ogilvy Healthworld UK, OgilvyHealthPR, WPP, medical communications, ogilvy healthworld advertising
Communications giant WPP has merged the digital activities of two media brands to launch a new entity in the UK, …
UCB and Amgen’s osteoporosis drug shows promise
April 21, 2011Research and Development Amgen, UCB, osteoporosis
Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …
Report sounds off-label prescribing warning
April 21, 2011Sales and Marketing EAASM, off label
A pharma-backed group has warned that some ‘off-label’ prescribing is dangerous for patients. A report by the European Alliance for …
Trevor Smith to lead Takeda in Europe
April 21, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Saving billions through ‘innovation’ – can the NHS pull it off?
April 21, 2011NHS reforms
Innovation is not a concept immediately associated with the UK’s national health service, but is now being promoted by the …
Procurement pitfalls and hurdles of lab equipment for clinical trials
April 20, 2011Research and Development clinical trials, medical equipment, mesm, procurement
Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
